LIR-1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody-dependent cellular cytotoxicity.

Leijonhufvud, Caroline; Reger, Robert; Segerberg, Filip; Theorell, Jakob; Schlums, Heinrich; Bryceson, Yenan T; Childs, Richard W; Carlsten, Mattias

Leijonhufvud, Caroline; Reger, Robert; Segerberg, Filip; Theorell, Jakob; Schlums, Heinrich; Bryceson, Yenan T; Childs, Richard W; Carlsten, Mattias.

Afiliação

Leijonhufvud C; Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden.
Reger R; Cellular and Molecular Therapeutics Branch National Heart, Lung, and Blood Institute National Institutes of Health Bethesda MD USA.
Segerberg F; Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden.
Theorell J; Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden.
Schlums H; Oxford Autoimmune Neurology Group Nuffield Department of Clinical Neurosciences University of Oxford Oxford UK.
Bryceson YT; Department of Clinical Neuroscience Centre for Molecular Medicine Karolinska Institute Karolinska University Hospital Stockholm Sweden.
Childs RW; Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden.
Carlsten M; Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden.

Clin Transl Immunology ; 10(10): e1346, 2021.

Article em En | MEDLINE | ID: mdl-34631057

Palavras-chave

LIR1; NK cell education; NK cells; antibodydependent cellular cytotoxicity; cancer immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Transl Immunology Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google